Small molecule drug development for rare genodermatoses – evaluation of the current status in epider...
Small molecule drug development for rare genodermatoses – evaluation of the current status in epidermolysis bullosa
About this item
Full title
Author / Creator
Publisher
London: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Hereditary epidermolysis bullosa (EB) comprises a heterogeneous group of rare genodermatoses, which are caused by mutations in genes involved in the maintenance of the structural and functional integrity of dermo-epidermal adhesion in various stratified epithelia. In severe variants, generalized skin disease, extracutaneous manifestations and multi...
Alternative Titles
Full title
Small molecule drug development for rare genodermatoses – evaluation of the current status in epidermolysis bullosa
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_2a582ac05c5b4cf7a645b2b2402a5186
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2a582ac05c5b4cf7a645b2b2402a5186
Other Identifiers
ISSN
1750-1172
E-ISSN
1750-1172
DOI
10.1186/s13023-020-01467-9
